• Aleafia Health’s (AH) everyday cannabis brand Divvy launches large-format dried flower portfolio
  • The new products strengthen the existing Divvy portfolio following a successful launch in Ontario’s adult-use market
  • The Divvy brand targets the important dried flower and pre-roll market, which represented 70 per cent of total legal cannabis sales during the three months
  • The new SKUs will be first available in Alberta, with expected roll-out to additional provinces
  • Aleafia Health Inc. (AH) is down 1.15 per cent and is trading at C$0.43 at 11:37 am ET

Aleafia Health Inc. (AH) has launch four new large-format offerings under its everyday cannabis brand Divvy.

The new products strengthen the existing Divvy portfolio following a successful launch in Ontario’s adult-use market.

In launching the new large format offerings,  14 gram pouches and 10 gram pre-milled flowers were added for consumer convenience.

The Divvy brand targets the important dried flower and pre-roll market, which represented 70 per cent of total legal cannabis sales during the three months ended December 31, 2020, according to data from the Ontario Cannabis Store.

The 14-gram pouches feature Divvy’s signature THC strain Sour Kush, and the newly launched sativa-leaning cultivar Flo.

Flo’s high-potency and unique terpene profile makes it a highly sought after cultivar not yet available in the legal Canadian cannabis market.

It is the first new strain brought to market as part of the Company’s extensive new genetic research and development program. The 10-gram pre-milled offering includes two initial SKUs featuring either select indica or sativa-dominant cultivars.

“The Divvy brand is making waves in the all-important dried flower and pre-roll categories by offering outstanding product quality and accessible pricing for cannabis consumers,” said Aleafia Health CEO Geoffrey Benic.

Divvy, part of the Sunday Market brand family, features five distinct brands with differentiated products tailored to specific consumer segments.

Divvy leverages Aleafia Health’s core competitive advantage of low-cost cultivation both at its Niagara Greenhouse facility and Port Perry outdoor cultivation facility. The new SKUs will be first available in Alberta, with expected roll-out to additional provinces.

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany.

Aleafia Health Inc. (AH) is down 1.15 per cent and is trading at C$0.43 at 11:37 am ET.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.